Zimmer Biomet Holdings IncZBH
Price$88.83Intrinsic value$105.8819% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $105.88median of 6 methods · middle span $99-$127based on filings through 30 Jun 2026
Market Price $88.83Price as of 30 Sep 2026
Margin of Safety +19.2%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 6.9% (near-term consensus, capped) · years 2–5: 5.6%/yr (balance of the path).5.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 65.1%Yr 74.6%Yr 84.0%Yr 93.5%Yr 103.0%
5.6% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (6y) (limited history)-7.0%
Discount rate (cost of equity) 7.8%
Volatility vs market (adjusted beta)0.64

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetZimmer Biomet Holdings IncZBHHealth Care
Valuation
P/E21.6×
P/S2.1×
P/B1.5×
EV / Revenue2.9×
EV / EBITDA10.4×
Profitability
Gross margin61.6%
Operating margin13.3%
Net margin9.5%
FCF margin17.9%
Returns
ROE6.4%
ROA3.5%
ROIC4.1%
Growth
Revenue growth (YoY)10.8%
5-yr fwd EPS growth5.9%
Financial strength
Debt / Equity0.59×
Current ratio1.69×
Altman Z-Score2.5
Interest coverage—
Dividend yield0.5%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.